Zentalis Pharmaceuticals Statistics

Total Valuation

ZNTL has a market cap or net worth of $100.43 million. The enterprise value is -$139.81 million.

Market Cap	100.43M
Enterprise Value	-139.81M

Important Dates

The last earnings date was Monday, November 10, 2025, after market close.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

ZNTL has 72.25 million shares outstanding. The number of shares has increased by 1.13% in one year.

Current Share Class	72.25M
Shares Outstanding	72.25M
Shares Change (YoY)	+1.13%
Shares Change (QoQ)	+0.20%
Owned by Insiders (%)	1.59%
Owned by Institutions (%)	54.09%
Float	50.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.71
Forward PS	n/a
PB Ratio	0.40
P/TBV Ratio	0.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.76, with a Debt / Equity ratio of 0.16.

Current Ratio	7.76
Quick Ratio	7.55
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -49.18% and return on invested capital (ROIC) is -27.60%.

Return on Equity (ROE)	-49.18%
Return on Assets (ROA)	-24.51%
Return on Invested Capital (ROIC)	-27.60%
Return on Capital Employed (ROCE)	-52.58%
Revenue Per Employee	$161,837
Profits Per Employee	-$899,494
Employee Count	166
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	-205,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.00% in the last 52 weeks. The beta is 1.75, so ZNTL's price volatility has been higher than the market average.

Beta (5Y)	1.75
52-Week Price Change	-59.00%
50-Day Moving Average	1.48
200-Day Moving Average	1.49
Relative Strength Index (RSI)	48.20
Average Volume (20 Days)	550,991

Short Selling Information

The latest short interest is 5.08 million, so 7.04% of the outstanding shares have been sold short.

Short Interest	5.08M
Short Previous Month	4.99M
Short % of Shares Out	7.04%
Short % of Float	10.15%
Short Ratio (days to cover)	6.73

Income Statement

In the last 12 months, ZNTL had revenue of $26.87 million and -$149.32 million in losses. Loss per share was -$2.08.

Revenue	26.87M
Gross Profit	26.87M
Operating Income	-152.53M
Pretax Income	-149.52M
Net Income	-149.32M
EBITDA	-151.63M
EBIT	-152.53M
Loss Per Share	-$2.08

Full Income Statement

Balance Sheet

The company has $280.70 million in cash and $40.46 million in debt, giving a net cash position of $240.24 million or $3.33 per share.

Cash & Cash Equivalents	280.70M
Total Debt	40.46M
Net Cash	240.24M
Net Cash Per Share	$3.33
Equity (Book Value)	252.87M
Book Value Per Share	3.50
Working Capital	251.13M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-134.01M
Capital Expenditures	n/a
Free Cash Flow	-134.01M
FCF Per Share	-$1.85

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-567.77%
Pretax Margin	-556.56%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ZNTL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.13%
Shareholder Yield	-1.13%
Earnings Yield	-148.68%
FCF Yield	-133.44%

Dividend Details

Analyst Forecast

The average price target for ZNTL is $5.87, which is 322.30% higher than the current price. The consensus rating is "Buy".

Price Target	$5.87
Price Target Difference	322.30%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	26.43%
EPS Growth Forecast (5Y)	-56.74%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ZNTL has an Altman Z-Score of -4.29 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.29
Piotroski F-Score	2